Current projections suggest the following timeline: Phase 3 trials complete around 2026 Regulatory submissions occur shortly after Potential approval may occur between 2027 and 2028 if results remain favorable (GLP3 Planner) These timelines depend heavily on: Final safety data Regulatory review Post-trial analyses Drug development is inherently uncertain, and unexpected findings can delay approval
We found that patients who took semaglutide had significantly lower readmissions and prosthetic joint infections following hip replacements, and they needed fewer revisions, he says
So the best way to understand them is not as a single winner board, but as a plain-language map of where the market stands right now
Weeks 9-12: 8 mg per week (160 units, requires 2 draws from 1 mL syringe or a larger syringe) The 8 mg dose is where retatrutide separates from the competition
refer to the batch certificate of analysis for lot-specific shelf life data Short-term (lyophilized) : 28 C acceptable for shorter storage periods Post-reconstitution : Refrigerate at 28 C and use within the timeframe specified by the research protocol or product documentation Protect from light, heat, and moisture at all times
Three months ago I stepped on the scale at 198 pounds
